No Data
No Data
From Comfort to Cure: 2024 ASCO Meeting Reveals Groundbreaking Oncology Data
USA News Group – This year's 2024 Annual Meeting of the American Society of Clinical Oncology (ASCO) has now come and gone, but not without...
AstraZeneca's Truqap Flops in Phase III Triple Negative Breast Cancer Trial
SAS Expands Portfolio of Data and AI Solutions for Life Sciences and Health Care
New clinical data repository built on SAS Viya offers an open, cloud-native, and scalable analytics platform to boost productivity and accelerate innovationCARY, N.C., June 18, 2024 /PRNewswire/ -- D
Mika Health Collaborates With AstraZeneca and Daiichi Sankyo to Deliver AI-Enabled Mobile Support to Women Undergoing Breast Cancer Treatment
AMSTERDAM, June 18, 2024 (GLOBE NEWSWIRE) -- Mika Health, a global digital therapeutics developer specializing in meeting the needs of cancer patients, in collaboration with AstraZeneca and Daiichi Sankyo, today
AstraZeneca's (AZN) Truqap Misses Endpoints in TNBC Study
AstraZeneca's Combination Cancer Drug For Advanced Breast Cancer Study Flunks Late-Stage Trial
Tuesday, AstraZeneca Plc (NASDAQ:AZN) announced topline data from the CAPItello-290 Phase 3 trial for Truqap (capivasertib) in combination with paclitaxel in patients with locally advanced (inoperable
No Data